A COVID-19 rapid testing kit developed by the Industrial Technology Research Institute (ITRI) should be ready for mass production as soon as July, officials announced yesterday.
The kit, which works by testing nucleic acids, can produce results within one hour, Deputy Minister of Economic Affairs Lin Chuan-neng (林全能) told a news conference at the Executive Yuan in Taipei, adding that this brings researchers one step closer to developing a vaccine.
The government has invested NT$2.16 billion (US$71.7 million) in the testing, treatment, prevention and research of the disease, National Health Research Institute (NHRI) president Liang Kung-yee (梁賡義) said.
Photo: Chen Yu-fu, Taipei Times
The nation is developing three testing methods, he said.
The first involves testing nucleic acids, which was the focus of the research at the ITRI, he said.
Another method involves testing nucleocapsid and spike proteins, which is being developed by researchers from Academia Sinica and the NHRI, he said.
That test could produce results in 15 to 20 minutes, and might also be ready for mass production by July, he said.
Nearly 20 companies attended an information session held by Academia Sinica and the NHRI to present their research, five of which expressed an interest in producing the test, he said.
The third type involves testing antibodies produced by the human body, and could be used on patients in recovery, he said.
Research on this method, which can produce results in 15 to 20 minutes, is being done at Chang Gung University in Taoyuan, he said, adding that mass production could commence in October.
“It is possible that COVID-19 will mutate into a form of influenza,” Liang said, adding that a vaccine and effective medication for treatment would be crucial if that happens.
The NHRI and Academia Sinica had already produced a 10g sample of their testing compound and could go into production now, he said.
Researchers are also experimenting with a combination of the Japanese antiviral drug favipiravir and other drugs for the treatment of patients with mild to moderate symptoms, he said.
The drug’s effectiveness against COVID-19 is being compared with that of another antiviral medication, remdesivir, and a synthesized drug has shown promise, he said, adding that companies have shown an interest in producing it.
A third drug, quinine — which is commonly used to treat malaria and babesiosis — has also shown promise in the treatment of COVID-19 patients with mild symptoms, he said.
Moreover, researchers have been separately developing six possible vaccines since late January and hope to arrive at a solution by the end of next month.
“If everything goes smoothly, we could see clinical trials by the end of the year,” he said.
“Several countries have expressed hope to work with Taiwan to produce a vaccine and rapid test,” he said.
CROSS-STRAIT COLLABORATION: The new KMT chairwoman expressed interest in meeting the Chinese president from the start, but she’ll have to pay to get in Beijing allegedly agreed to let Chinese Nationalist Party (KMT) Chairwoman Cheng Li-wun (鄭麗文) meet with Chinese President Xi Jinping (習近平) around the Lunar New Year holiday next year on three conditions, including that the KMT block Taiwan’s arms purchases, a source said yesterday. Cheng has expressed interest in meeting Xi since she won the KMT’s chairmanship election in October. A source, speaking on condition of anonymity, said a consensus on a meeting was allegedly reached after two KMT vice chairmen visited China’s Taiwan Affairs Office Director Song Tao (宋濤) in China last month. Beijing allegedly gave the KMT three conditions it had to
STAYING ALERT: China this week deployed its largest maritime show of force to date in the region, prompting concern in Taipei and Tokyo, which Beijing has brushed off Deterring conflict over Taiwan is a priority, the White House said in its National Security Strategy published yesterday, which also called on Japan and South Korea to increase their defense spending to help protect the first island chain. Taiwan is strategically positioned between Northeast and Southeast Asia, and provides direct access to the second island chain, with one-third of global shipping passing through the South China Sea, the report said. Given the implications for the US economy, along with Taiwan’s dominance in semiconductors, “deterring a conflict over Taiwan, ideally by preserving military overmatch, is a priority,” it said. However, the strategy also reiterated
‘BALANCE OF POWER’: Hegseth said that the US did not want to ‘strangle’ China, but to ensure that none of Washington’s allies would be vulnerable to military aggression Washington has no intention of changing the “status quo” in the Taiwan Strait, US Secretary of Defense Pete Hegseth said on Saturday, adding that one of the US military’s main priorities is to deter China “through strength, not through confrontation.” Speaking at the annual Reagan National Defense Forum in Simi Valley, California, Hegseth outlined the US Department of Defense’s priorities under US President Donald Trump. “First, defending the US homeland and our hemisphere. Second, deterring China through strength, not confrontation. Third, increased burden sharing for us, allies and partners. And fourth, supercharging the US defense industrial base,” he said. US-China relations under
The Chien Feng IV (勁蜂, Mighty Hornet) loitering munition is on track to enter flight tests next month in connection with potential adoption by Taiwanese and US armed forces, a government source said yesterday. The kamikaze drone, which boasts a range of 1,000km, debuted at the Taipei Aerospace and Defense Technology Exhibition in September, the official said on condition of anonymity. The Chungshan Institute of Science and Technology and US-based Kratos Defense jointly developed the platform by leveraging the engine and airframe of the latter’s MQM-178 Firejet target drone, they said. The uncrewed aerial vehicle is designed to utilize an artificial intelligence computer
RSS